Navigation Links
Axial Biotech Wins 2009 Innovation Award for Biotechnology
Date:5/4/2009

Company recognized from more than 100 companies for innovative technology

SALT LAKE CITY, May 4 /PRNewswire/ -- Axial Biotech, Inc., a company revolutionizing spine care through the development of molecular diagnostic technologies, was selected as the winner at the 9th Annual Utah Innovation Award Ceremony. The award recognizes significant innovations and the companies that created them. The Utah Technology Council and Stoel Rives, LLP presented the award to Axial Biotech during an awards ceremony held Thursday, April 30, 2009.

Axial Biotech's award winning product, ScoliScore(TM), is the first-ever genetic test for patients diagnosed with Adolescent Idiopathic Scoliosis (AIS). This new molecular diagnostic tool marks a major advancement in which medical treatments can be personalized to patients diagnosed with this deforming disease.

ScoliScore(TM) was developed by utilizing a genome wide association study that identified a panel of genetic markers associated with severe curve progression. The scoliosis research used in the development of this test included collecting DNA samples from over 9,500 patients from 85 clinical sites throughout the world. The test was then further validated in two separate clinical trials.

"We are honored to have won the Biotechnology/Pharmaceutical category given that the other finalists were Nanopartz and GlycoMira, LLC, which are both remarkable companies that have developed impressive technologies," said Kenneth Ward, M.D., Chairmen of the Board and Chief Medical Officer. "Past winners in the Biotechnology category include the 2004 winner, ARUP Laboratories, a leading national diagnostic reference laboratory. To have Axial Biotech viewed in this same league represents an important accomplishment for our company."

John Climaco, CEO and President of Axial Biotech, said, "I am pleased that the distinguished panel of experts from private industry,
'/>"/>

SOURCE Axial Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Axial Biotech Appoints Dr. Roberto Macina to Vice President of Research and Development
2. Axial Biotech Launches Genetic Test for Adolescent Idiopathic Scoliosis (AIS)
3. Axial Biotech Appoints Retired Roche Diagnostics Executive to Board
4. Axial Biotech appoints new Vice President of Strategic Initiatives
5. Axial Biotech Names New VP of Reimbursement and Regulatory Affairs
6. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
7. Pulmo BioTech Inc. Announces Paper to be Presented at Symposium
8. Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day
9. ALS Therapy Development Institute, the Worlds Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer
10. Sinovac Biotech Ltd. Files Annual Report on Form 20-F
11. Biotech Drops on Weaker First Quarter Drug Sales, But Broader Markets Remain on a Roll

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...FirstCall/--ArdeaBiosciences,Inc.(Nasdaq: RDEA )an...chiefexecutiveofficer,willpresentatthePiperJaffray...tailsareasfollows:,PiperJaffray21stAnnualHealthCa...p.m.EasternTime,Location:TheNewYorkPalaceHotel,New...t/ireye/,target=,_blank,title=,http://www.corpora...
(Date:11/24/2009)...ewswire/--Twomoreprestigiousuniversitieshavejoined...dcareerssiteforlifescienceprofessionals. ,, Nor...bboard,joining28othermajorlifesciencetrainingInsti...m ,isonlyforpost-graduatesinthelifesciences.Whilet...et,BioCareerCenteristheonlyonethatserveslifescienc...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasd...stday"motionsbytheU.S.BankruptcyCourtfortheDistric...iledavoluntarypetitionfor,reliefunderChapter11ofth.... , TheordersissuedbytheBankruptcyCourtallowt...hapter11proceedings.Inparticular,the,companyreceiv...
(Date:11/24/2009)...ecently approved the Promega PowerPlex 16 HS Syste...rating DNA records for the National DNA Index Syst...WEB) -- The FBI recently approved the Promega Pow...participating in, or generating DNA records for, t...y contains more than seven million profiles and ha...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...ta Green, a Project Which Will Leverage Rosetta Ge...ng IP Position to Develop a Wide ...s Recently Secured Up to $1.5M From Private Invest...renches as Certain Milestones are ...fied microRNAs Correlated With Algal Oil Content ...
...howed Patients Experienced Improvements in Quality...th Other Anti-TNFs or Methotrexate, SAN FRANCISCO... that patients receiving every four week subcutane...0 mg, an investigational therapy,experienced signi...elated,quality of life (HRQOL) and fatigue. The da...
... Oct. 27 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,...cturer and supplier of,modernized traditional Chin... announced that the Company will present at the Ro... on Tuesday, November 11th, 2008. The,Conference w...ce Hotel in,New York City., The Company,s present...
Other Biology Technology:Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 2Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 3Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 4Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 2Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 3Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 4Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 5Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 6Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 7Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 8Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 9Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST 2Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST 3
(Date:11/26/2009)...cillin-resistant Staphylococcus Aureus ) and othe...as low-temperature plasma prototype devices have b...ling bactericidal cocktails. , Two prototype dev...ection of healthy skin (e.g. hands and feet) in ho...a lethal threat; and another to shoot bacteria-kil...
(Date:11/25/2009)...r 11, firefighters, police officers and ambulance ...rld Trade Center complex. They battled to save peo...survivors, tackled fires and evacuated as many peo...timated 17,000 people. And making their jobs even ...ghtened workers and their relatives jammed mobile ...
(Date:11/25/2009)...ate University assistant professors recently recei...NSF) to continue research beneficial to understand...00. , Christopher Blackwood, assistant professor...rded grants to support two separate research proje...ter Decomposer Communities and Functions from the ...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 1Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 2Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 3Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 4Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 5Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 6Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 7Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 8Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 9Is it Exam Time for Students Already 3F 56191 1Is it Exam Time for Students Already 3F 56191 2Is it Exam Time for Students Already 3F 56191 3Is it Exam Time for Students Already 3F 56191 4Is it Exam Time for Students Already 3F 56191 5Adamas Pharmaceuticals to Present Data on Triple Combination Antiviral Drug Therapy for Drug Resistant Influenza at 2009 ICAAC Annual Meeting 13842 1Adamas Pharmaceuticals to Present Data on Triple Combination Antiviral Drug Therapy for Drug Resistant Influenza at 2009 ICAAC Annual Meeting 13842 2
... research shows that certain genes can influence a...es, cancer for example. New research at the Masoni...tes that genetic markers may also show a person,s ...rch study led by Brian Van Ness, Ph.D., has succes... with early clinical relapse of multiple myeloma, ...
...LE, Ariz. Oct. 21, 2008 TGen has spun off its th...medical information source for oncologists. , The...on a variety of data sources, including genetic-ba...-based Translational Genomics Research Institute. ...e oncologists with the knowledge they need to desi...
...zambiquein response to the urgent need to reduce t... Council for Science (ICSU) has launched a new, 10...o address the gaps in the knowledge and methods th...ence to averting disasters and reducing risk. The ...eral Assembly in Maputo, Mozambique. , Each year ...
Other Biology News:U of MN study shows link between gene variations and cancer survival 2TGen spin-off MedTrust Online enables cancer doctors to quickly obtain best-available information 2International Council for Science launches major research program on natural disasters 2
...GFX Purification Kit, 24 reactions. For the genera....Optimized reagents are packaged together for comp...ptimized protocols can be used for performing labe...leotides.Reliable purification using the CyScribe ...
Canine serum from Equitech-Bio
UV-NIR light source for USB2000, HR4000, HR2000+ from Ocean Optics
Mouse Anti-Human SIGIRR Monoclonal Antibody, Unconjugated, Clone 162201 from R&D Systems
Biology Products: